Roche readies for biosimilar Herceptin in Europe

04:56 EST 15 Feb 2018 | SmartBrief

Celltrion's biosimilar version of Roche's breast cancer drug Herceptin is about to hit the European market, and more biosimil -More

Original Article: Roche readies for biosimilar Herceptin in Europe


More From BioPortfolio on "Roche readies for biosimilar Herceptin in Europe"

Quick Search


Relevant Topics

Biosimilars or Follow-on biologics are terms used to describe officially approved subsequent versions of innovator biopharmaceutical products made by a different sponsor following patent and exclusivity expiry on the innovator product. Products that ar...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...

Breast Cancer
Track and monitor developments in breast cancer research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on breast cancer and follow companies active in the development of breast cancer tr...